Fragile X syndrome

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Fragile X syndrome (FXS), also known as Martin-Bell syndrome, is the most common inherited cause of intellectual disability (ID), and it is the most common known single-gene cause of autism or autism spectrum disorders (ASDs). It is caused by a trinucleotide repeat (CGG) expansion at the 5' noncoding region of the fragile X mental retardation 1 (FMR1) gene located on the long arm of the X chromosome at band Xq27.3. Large expansions (>200 CGG repeats) cause hypermethylation and silencing of the gene, leading to a loss of the gene product, fragile X mental retardation protein (FMRP). The resulting phenotype is complex and consists of cognitive impairments, difficulties with emotional and behavioral regulation, and certain physical characteristics as well, all elaborated upon later in this chapter. However, even smaller expansions (between 55 and 200 repeats) within the premutation range with normal or close-to-normal levels of FMRP can also result in clinical complications of its own. This is due in large part to the increased transcription of FMR1 mRNA seen in premutation carriers, which can be toxic to cells, particularly neurons and astrocytes. The resulting premutation-associated disorders are discussed at length in the second part of this chapter. Finally, pharmacological interventions that are still being studied are discussed. These pharmaceuticals, including mGluR5 antagonists and GABA agonists, seek to restore the imbalance of neurotransmission in FXS and have led to some promising preliminary results in mitigating or even reversing the neurobiological abnormalities caused by the loss of FMRP.

Original languageEnglish (US)
Title of host publicationNeuroscience in the 21st Century
Subtitle of host publicationFrom Basic to Clinical, Second Edition
PublisherSpringer New York
Pages3189-3210
Number of pages22
ISBN (Electronic)9781493934744
ISBN (Print)9781493934737
DOIs
StatePublished - Jan 1 2016

Fingerprint

Fragile X Mental Retardation Protein
Fragile X Syndrome
Intellectual Disability
Trinucleotide Repeat Expansion
Genes
GABA Agonists
genes
proteins
Poisons
astrocytes
X Chromosome
Gene Silencing
gene silencing
X chromosome
Autistic Disorder
Synaptic Transmission
Astrocytes
agonists
antagonists
Reference Values

Keywords

  • Anxiety
  • Attention deficit/hyperactivity disorder (ADHD)
  • Autism
  • CGG repeats
  • Fragile X syndrome (FXS)
  • Gamma-aminobutyric acid (GABA)
  • Hypotonia
  • Intellectual disability
  • Matrix metalloproteinase 9 (MMP9)
  • Methylation
  • Minocycline
  • RNA toxicity
  • Seizures
  • Sleep disturbances
  • Tremor/ataxia syndrome

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)
  • Agricultural and Biological Sciences(all)

Cite this

Au, J., & Hagerman, R. J. (2016). Fragile X syndrome. In Neuroscience in the 21st Century: From Basic to Clinical, Second Edition (pp. 3189-3210). Springer New York. https://doi.org/10.1007/978-1-4939-3474-4_89

Fragile X syndrome. / Au, Jacky; Hagerman, Randi J.

Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York, 2016. p. 3189-3210.

Research output: Chapter in Book/Report/Conference proceedingChapter

Au, J & Hagerman, RJ 2016, Fragile X syndrome. in Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York, pp. 3189-3210. https://doi.org/10.1007/978-1-4939-3474-4_89
Au J, Hagerman RJ. Fragile X syndrome. In Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York. 2016. p. 3189-3210 https://doi.org/10.1007/978-1-4939-3474-4_89
Au, Jacky ; Hagerman, Randi J. / Fragile X syndrome. Neuroscience in the 21st Century: From Basic to Clinical, Second Edition. Springer New York, 2016. pp. 3189-3210
@inbook{ef4e72e6434342e8a382dddd1e6ba563,
title = "Fragile X syndrome",
abstract = "Fragile X syndrome (FXS), also known as Martin-Bell syndrome, is the most common inherited cause of intellectual disability (ID), and it is the most common known single-gene cause of autism or autism spectrum disorders (ASDs). It is caused by a trinucleotide repeat (CGG) expansion at the 5' noncoding region of the fragile X mental retardation 1 (FMR1) gene located on the long arm of the X chromosome at band Xq27.3. Large expansions (>200 CGG repeats) cause hypermethylation and silencing of the gene, leading to a loss of the gene product, fragile X mental retardation protein (FMRP). The resulting phenotype is complex and consists of cognitive impairments, difficulties with emotional and behavioral regulation, and certain physical characteristics as well, all elaborated upon later in this chapter. However, even smaller expansions (between 55 and 200 repeats) within the premutation range with normal or close-to-normal levels of FMRP can also result in clinical complications of its own. This is due in large part to the increased transcription of FMR1 mRNA seen in premutation carriers, which can be toxic to cells, particularly neurons and astrocytes. The resulting premutation-associated disorders are discussed at length in the second part of this chapter. Finally, pharmacological interventions that are still being studied are discussed. These pharmaceuticals, including mGluR5 antagonists and GABA agonists, seek to restore the imbalance of neurotransmission in FXS and have led to some promising preliminary results in mitigating or even reversing the neurobiological abnormalities caused by the loss of FMRP.",
keywords = "Anxiety, Attention deficit/hyperactivity disorder (ADHD), Autism, CGG repeats, Fragile X syndrome (FXS), Gamma-aminobutyric acid (GABA), Hypotonia, Intellectual disability, Matrix metalloproteinase 9 (MMP9), Methylation, Minocycline, RNA toxicity, Seizures, Sleep disturbances, Tremor/ataxia syndrome",
author = "Jacky Au and Hagerman, {Randi J}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-3474-4_89",
language = "English (US)",
isbn = "9781493934737",
pages = "3189--3210",
booktitle = "Neuroscience in the 21st Century",
publisher = "Springer New York",

}

TY - CHAP

T1 - Fragile X syndrome

AU - Au, Jacky

AU - Hagerman, Randi J

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Fragile X syndrome (FXS), also known as Martin-Bell syndrome, is the most common inherited cause of intellectual disability (ID), and it is the most common known single-gene cause of autism or autism spectrum disorders (ASDs). It is caused by a trinucleotide repeat (CGG) expansion at the 5' noncoding region of the fragile X mental retardation 1 (FMR1) gene located on the long arm of the X chromosome at band Xq27.3. Large expansions (>200 CGG repeats) cause hypermethylation and silencing of the gene, leading to a loss of the gene product, fragile X mental retardation protein (FMRP). The resulting phenotype is complex and consists of cognitive impairments, difficulties with emotional and behavioral regulation, and certain physical characteristics as well, all elaborated upon later in this chapter. However, even smaller expansions (between 55 and 200 repeats) within the premutation range with normal or close-to-normal levels of FMRP can also result in clinical complications of its own. This is due in large part to the increased transcription of FMR1 mRNA seen in premutation carriers, which can be toxic to cells, particularly neurons and astrocytes. The resulting premutation-associated disorders are discussed at length in the second part of this chapter. Finally, pharmacological interventions that are still being studied are discussed. These pharmaceuticals, including mGluR5 antagonists and GABA agonists, seek to restore the imbalance of neurotransmission in FXS and have led to some promising preliminary results in mitigating or even reversing the neurobiological abnormalities caused by the loss of FMRP.

AB - Fragile X syndrome (FXS), also known as Martin-Bell syndrome, is the most common inherited cause of intellectual disability (ID), and it is the most common known single-gene cause of autism or autism spectrum disorders (ASDs). It is caused by a trinucleotide repeat (CGG) expansion at the 5' noncoding region of the fragile X mental retardation 1 (FMR1) gene located on the long arm of the X chromosome at band Xq27.3. Large expansions (>200 CGG repeats) cause hypermethylation and silencing of the gene, leading to a loss of the gene product, fragile X mental retardation protein (FMRP). The resulting phenotype is complex and consists of cognitive impairments, difficulties with emotional and behavioral regulation, and certain physical characteristics as well, all elaborated upon later in this chapter. However, even smaller expansions (between 55 and 200 repeats) within the premutation range with normal or close-to-normal levels of FMRP can also result in clinical complications of its own. This is due in large part to the increased transcription of FMR1 mRNA seen in premutation carriers, which can be toxic to cells, particularly neurons and astrocytes. The resulting premutation-associated disorders are discussed at length in the second part of this chapter. Finally, pharmacological interventions that are still being studied are discussed. These pharmaceuticals, including mGluR5 antagonists and GABA agonists, seek to restore the imbalance of neurotransmission in FXS and have led to some promising preliminary results in mitigating or even reversing the neurobiological abnormalities caused by the loss of FMRP.

KW - Anxiety

KW - Attention deficit/hyperactivity disorder (ADHD)

KW - Autism

KW - CGG repeats

KW - Fragile X syndrome (FXS)

KW - Gamma-aminobutyric acid (GABA)

KW - Hypotonia

KW - Intellectual disability

KW - Matrix metalloproteinase 9 (MMP9)

KW - Methylation

KW - Minocycline

KW - RNA toxicity

KW - Seizures

KW - Sleep disturbances

KW - Tremor/ataxia syndrome

UR - http://www.scopus.com/inward/record.url?scp=85018896024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018896024&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-3474-4_89

DO - 10.1007/978-1-4939-3474-4_89

M3 - Chapter

SN - 9781493934737

SP - 3189

EP - 3210

BT - Neuroscience in the 21st Century

PB - Springer New York

ER -